| abstract |
Pharmaceuticals suitable for preparing pharmaceutical formulations containing immunomodulatory peptide inhibitors are described herein. Pharmaceutical formulations containing immunomodulatory peptide inhibitors are described herein. Also described herein are methods of ameliorating, suppressing, reducing, or treating cancer symptoms by administering pharmaceutical formulations containing immunomodulatory peptide inhibitors. [Choice diagram] Fig. 1A |